EVAR术后长期肾功能下降与对比剂用量高于PAD患者相关
该回顾性研究将214例EVAR患者与214例PAD患者按倾向性匹配,中位随访8.4年,发现EVAR患者对比剂检查次数和用量更高,随访9年后肾小球滤过率出现显著下降,但透析依赖和死亡率无显著差异。
要点
- EVAR患者对比剂检查次数6.0 vs PAD 3.0(P<0.001),对比剂用量665 mL vs 420 mL(P<0.0001)。
- 随访9年后EVAR患者肾小球滤过率较PAD患者显著下降,此前无差异。
- 肾上型与肾下型固定EVAR患者肾功能变化无显著差异。
核心结论
- EVAR患者随访9年后肾小球滤过率较倾向性匹配的PAD患者显著持续下降,可能与时程中对比剂检查次数和用量更高有关。
- 肾上型固定与肾下型固定相比,长期肾功能无显著负面影响。
研究设计与样本
- 回顾性分析2006年7月至2013年7月连续接受EVAR或针对症状性下肢动脉闭塞性疾病(PAD)血管造影的患者。
- 按糖尿病、高血压、吸烟史、慢性肾脏病分期、年龄、性别和种族进行倾向性匹配,生成214例EVAR和214例PAD队列,中位随访8.4年。
- 另对104例肾上型或肾下型固定的EVAR患者进行倾向性匹配队列分析。
主要发现
- EVAR患者后续透析依赖率1.4% vs PAD 2.3%(P=0.502),死亡率41.8% vs 40.4%(P=0.627),均无显著差异。
- EVAR患者对比剂检查次数6.0 vs PAD 3.0(P<0.001),对比剂用量665 mL vs 420 mL(P<0.0001)。
- EVAR患者肾小球滤过率在随访9年前稳定且与PAD患者无差异,9年后EVAR患者显示显著肾功能下降。
- 104例肾上型或肾下型固定EVAR患者倾向性匹配队列中,肾功能随时间变化无显著差异。
临床怎么用
- 根据血管外科学会推荐,对主动脉内移植物长期监测应审慎使用对比剂检查。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The impact of endovascular aortic aneurysm repair (EVAR) in subsequent renal dysfunction is unclear. We compared EVAR patients to those with disabling claudication or critical limb-threatening ischemia to discern long-term renal outcomes. METHODS: Retrospective analysis of consecutive patients who underwent EVAR or angiography for symptomatic lower extremity arterial occlusive disease (peripheral arterial disease [PAD]) from July 2006 to July 2013, propensity-matched for diabetes, hypertension, smoking history, chronic kidney disease stage, age, sex, and race. RESULTS: Cohorts of 214 propensity-matched EVAR and PAD patients were generated with median follow-up of 8.4 years. There were similar rates of subsequent dialysis dependence (1.4% vs. 2.3%, P = 0.502) and mortality (41.8% vs. 40.4%, P = 0.627), but more contrast studies and higher contrast volumes in EVAR patients (6.0 vs. 3.0, P < 0.001; 665 mL vs. 420 mL, P < 0.0001). In EVAR patients, glomerular filtration rate was stable and not different from PAD patients until 9 years of follow-up, when EVAR patients showed a significant decline in renal function. Additional propensity-matched cohorts of 104 EVAR patients with suprarenal or infrarenal fixation showed no significant differences in change in renal function over time. CONCLUSION: The significant, sustained relative deterioration in glomerular filtration rate seen after 9 years in EVAR patients compared to propensity-matched PAD patients may potentially be explained by the higher number of contrast studies and contrast volumes administered to EVAR patients over time. Suprarenal fixation does not appear to negatively impact long-term renal function compared with infrarenal fixation. As per Society for Vascular Surgery recommendations, contrast studies should be used judiciously for long-term surveillance of aortic endografts.
引用
- Long GW, Kumar M, Studzinski DM, et al. Long-Term Renal Function Decline is Associated With Higher Contrast Volume Administration After Endovascular Aortic Aneurysm Repair Compared to Patients With Peripheral Arterial Disease. Ann Vasc Surg. 2025. PMID: 40553845. doi:10.1016/j.avsg.2025.06.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。